Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 93: 857-864, 2002. First published May 17, 2002; doi:10.1152/japplphysiol.01103.2001
8750-7587/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
93/3/857    most recent
01103.2001v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (47)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halliwill, J. R.
Right arrow Articles by Minson, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halliwill, J. R.
Right arrow Articles by Minson, C. T.
Vol. 93, Issue 3, 857-864, September 2002

Effect of hypoxia on arterial baroreflex control of heart rate and muscle sympathetic nerve activity in humans

John R. Halliwill1 and Christopher T. Minson2

1 Department of Anesthesiology and General Clinical Research Center, Mayo Clinic and Foundation, Rochester, Minnesota 55905; and 2 Department of Exercise and Movement Science, University of Oregon, Eugene, Oregon 97403-1240


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

We tested the hypothesis that acute hypoxia would alter the sensitivity of arterial baroreflex control of both heart rate and sympathetic vasoconstrictor outflow. In 16 healthy, nonsmoking, normotensive subjects (8 women, 8 men, age 20-33 yr), we assessed baroreflex control of heart rate and muscle sympathetic nerve activity by using the modified Oxford technique during both normoxia and hypoxia (12% O2). Compared with normoxia, hypoxia reduced arterial O2 saturation levels from 96.8 ± 0.3 to 80.7 ± 1.4% (P < 0.001), increased heart rate from 59.8 ± 2.4 to 79.4 ± 2.9 beats/min (P < 0.001), increased mean arterial pressure from 96.7 ± 2.5 to 105.0 ± 3.3 mmHg (P = 0.002), and increased sympathetic activity 126 ± 58% (P < 0.05). The sensitivity for baroreflex control of both heart rate and sympathetic activity was not altered by hypoxia (heart rate: -1.02 ± 0.09 vs. -1.02 ± 0.11 beats · min-1 · mmHg-1; nerve activity: -5.6 ± 0.9 vs. -6.2 ± 0.9 integrated activity · beat-1 · mmHg-1; both P > 0.05). Acute exposure to hypoxia reset baroreflex control of both heart rate and sympathetic activity to higher pressures without changes in baroreflex sensitivity.

altitude; anoxia; sympathetic nervous system; syncope; orthostasis


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

EXPOSURE TO ALTITUDE OR BREATHING hypoxic air at sea level results in hypoxemia and leads to considerable reflex autonomic changes in respiratory and cardiovascular system function. There is a lack of information regarding how the physiological response to hypoxia affects the body's ability to respond to other stresses that occur in conjunction with hypoxia. In particular, hypoxia has been shown to reduce orthostatic tolerance in some humans (10, 19, 30, 36, 38, 49); however, the interactions between the pathways that maintain arterial pressure and those that respond to hypoxia (e.g., chemoreflexes) are poorly understood.

During orthostatic stress in humans, the arterial and cardiopulmonary baroreflexes play a key role in maintaining arterial pressure (and thereby preventing syncope) by increasing both heart rate and sympathetic nerve activity to vascular beds. With the addition of hypoxia, a greater increase in sympathetic outflow may be needed to overcome vasodilator effects of hypoxia on vascular tone (34, 48). Although it is clear that sympathetic outflow is augmented during exposure to hypoxia in humans (35, 40), it is unclear whether this is due to peripheral chemoreflex activation per se or a compensation for hypoxic vasodilation. Alternatively, whereas baroreflex control of sympathetic outflow to the vascular beds has not been assessed in humans during hypoxia, animal research has suggested that baroreflex control of sympathetic outflow is enhanced during hypoxia (23). One possibility is that changes in baroreflex function contribute to or even mediate the rise in sympathetic outflow. Further work suggests that baroreflex control of heart rate may be diminished by altitude or hypoxia (39), but there have been conflicting results (1, 6).

Therefore, the goal of the present study was to provide insight into cardiovascular regulation during hypoxia. We tested the hypothesis that acute hypoxia would alter the sensitivity of arterial baroreflex control of both heart rate and sympathetic vasoconstrictor outflow, resulting in augmented responses for a given change in pressure.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

This study was approved by the Institutional Review Board of the Mayo Clinic and Foundation, and each subject gave his or her informed written consent before participation. We assessed baroreflex control of heart rate and muscle sympathetic nerve activity by using the modified Oxford technique during both normoxia and hypoxia.

Subjects

Sixteen healthy, nonsmoking, normotensive subjects (8 women, 8 men) between the ages of 20 and 33 yr participated in this study [height 175 ± 10 (SD) cm, weight 69.6 ± 13.7 kg, body mass index 22.6 ± 3.3 kg/m2]. None of the subjects was taking medications other than oral contraceptives, and none had been at altitude (>1,500 m) for at least 5 mo. All female subjects had a negative serum pregnancy test within 12 h before participation.

Protocol

The purpose of this protocol was to assess the effect of hypoxia on baroreflex control of heart rate and muscle sympathetic nerve activity. Throughout this protocol, subjects were instrumented in the supine position for measurement of heart rate (electrocardiogram), beat-by-beat arterial pressure via finger photoplethysmography (Finapres blood pressure monitor, model 2300, Ohmeda, Englewood, CO), and arterial O2 saturation via pulse oximetry of the earlobe (Biox 3740 pulse oximeter, Ohmeda, Boulder, CO). An intravenous catheter was placed in an antecubital vein for administration of vasoactive substances for the purpose of assessing baroreflex responses. In nine of the subjects (3 women, 6 men), we recorded muscle sympathetic nerve activity from the fibular (peroneal) nerve via microneurography. In the remaining seven subjects, nerve recordings either were inadequate or were not stable during one or more of the trials.

During measurement periods, subjects breathed either room air (normoxia) or 12% O2 in N2 (hypoxia) via a two-way nonrebreathing valve. Subjects breathed through a scuba mouthpiece while nasal breathing was prevented with a nose clip. Ventilation was measured via a pneumotach (model VMM-2a, Interface Associates, Laguna Niguel, CA), and end-tidal CO2 was measured at the mouth via an infrared CO2 analyzer (model 1260, Novametrix Medical Systems, Wallingford, CT). After instrumentation, subjects underwent two 18-min measurement periods (normoxia and hypoxia) separated by a 20-min rest period. We continuously recorded heart rate, arterial pressure, ventilation, and sympathetic activity during each measurement period. We assessed baroreflex control of heart rate and muscle sympathetic nerve activity during minutes 15-18. Our laboratory's prior work has shown that repeated baroreflex trials separated by a 20-min rest period are reproducible (26, 37). Because hypoxia may have long-lasting effects (29), we did not randomize the order of trials between normoxia and hypoxia.

Muscle sympathetic nerve activity. Muscle sympathetic nerve activity was recorded via microneurography, as originally described by Sundlöf and Wallin (46). Multiunit postganglionic muscle sympathetic nerve activity was recorded from the fibular (peroneal) nerve posterior to the fibular head with a tungsten microelectrode. The recorded signal was amplified 100,000-fold, band-pass filtered (700-2,000 Hz), rectified, and integrated (resistance-capacitance integrator circuit, time constant 0.1 s) for analysis of muscle sympathetic nerve activity.

Baroreflex control of heart rate and sympathetic outflow. Baroreflex responses were assessed by measuring heart rate and muscle sympathetic nerve activity during arterial pressure changes induced by nitroprusside and phenylephrine as developed by Ebert and Cowley (5) and by Rudas et al. (37). During both normoxia and hypoxia, 100 µg sodium nitroprusside were given intravenously as a bolus, followed 1 min later by 150 µg phenylephrine HCl. This paradigm decreases arterial pressure ~15 mmHg below baseline levels and then increases it ~15 mmHg above baseline levels, over a short time course.

Data Analysis

Data were digitized at 250 Hz with signal-processing software (WinDaq, Dataq Instruments, Akron, OH) and analyzed off-line. Each muscle sympathetic nerve activity recording was normalized by assigning the largest sympathetic burst under resting conditions an amplitude of 1,000 (13). All other bursts for that recording were calibrated against that value. The zero nerve activity level was determined from the mean voltage during a period of neural silence between sympathetic bursts. A period in which bursts were absent for >5 s was found in each tracing and used for this purpose.

Baroreflex control of sympathetic outflow was determined from the relation between muscle sympathetic nerve activity and diastolic pressure during vasoactive drug boluses (5, 14, 37). The slope of this relation is used as an index of reflex sensitivity. The operating point for the relation in terms of resting arterial pressure and nerve activity was determined as the average values over the 5-min period immediately preceding the nitroprusside bolus. Diastolic pressure was used because muscle sympathetic nerve activity correlates closely with diastolic pressure but not with systolic pressure (37, 46). To perform a linear regression between nerve activity and pressure, values for nerve activity were first signal averaged over 3-mmHg pressure ranges via custom software as described previously (13). A window of nerve activity that was 2.0 s in length and synchronized by the R wave of the electrocardiogram was signal averaged. The window was time shifted to account for the latency between R waves and sympathetic bursting. The duration of the shift was varied as needed from subject to subject, but it averaged 1.3 s. Subsequently, the extreme ends of the window, which represented sympathetic bursts occurring in the preceding and following heartbeats, were truncated, and the total integrated activity was determined as the area under the signal-averaged curve. This was done for each 3-mmHg pressure range. The points of truncation for all windows in a given trial were set at the obvious nadirs between the burst of interest and the preceding and following bursts, and the same timing was used for all windows in a given trial.

Baroreflex control of heart rate was determined from the relation between heart rate and systolic pressure during vasoactive drug boluses (5, 14, 37). The slope of this relation is used as an index of reflex sensitivity. The operating point for the relation in terms of resting arterial pressure and heart rate was determined as the average values over the 5-min period immediately preceding the nitroprusside bolus. Systolic pressure was used because heart rate correlates closely with systolic pressure but not with diastolic pressure (37, 46). To perform a linear regression between heart rate and pressure, values for heart rate were first pooled over 2-mmHg pressure ranges as described previously (5, 14, 37). The analogous regression between R-R interval and systolic pressure was also determined.

A hysteresis, in which the slopes of falling and rising pressure responses can differ, has been observed in cardiac baroreflex responses in some studies (37). We independently assessed the falling and rising pressure portions of our data, comparing normoxia and hypoxia trials. No differences in baroreflex sensitivity between the falling and rising responses were observed in the data. Furthermore, there were no differences in the effect of hypoxia on baroreflex sensitivity between the falling and rising portions of the response. Finally, independent analysis of the falling and rising portions of the response resulted in poorer fit of the linear regression (on the basis of lower correlation coefficients). Therefore, data and comparisons based on the combined falling and rising response are presented in detail. However, we also present slope comparisons for the falling and rising response in Table 1.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Rising vs. falling pressure and heart rate responses

In animal models, it is often possible to assess baroreflex responses over a wider range of pressures so that response relations encompass the reflex from threshold to saturation. Such data can often be expressed by a sigmoidal equation. However, with the use of bolus administration of nitroprusside and phenylephrine in humans, we have not been able to characterize the entire response relationship consistently, because the nonlinear threshold and saturation regions are variably present. As such, we have restricted our analysis to the linear region of the reflex response, which appears to be the region in which the human arterial baroreflex generally operates (9). This approach necessitates visual selection by the investigator to identify the linear region on each individual baroreflex trial. Our laboratory has used this approach consistently in the past (14, 26, 27).

Statistics. Because there were no discernable differences between men and women, data from the two groups were combined for statistical analysis. Baseline variables measured during normoxia and hypoxia were compared by paired t-tests. Differences were considered significant when P < 0.05. All values are reported as means ± SE unless otherwise indicated.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Cardiovascular Responses to Hypoxia

As expected, arterial O2 saturation levels were lower during hypoxia (80.7 ± 1.4%) than during normoxia (96.8 ± 0.3%; P < 0.001), and this was associated with ventilatory responses characterized by a rise in ventilation from 4.9 ± 0.2 to 6.4 ± 0.4 l/min (P = 0.001) and a fall in end-tidal CO2 from 5.8 ± 0.2 to 5.1 ± 0.2% (P < 0.001). Hypoxia was associated with a rise in heart rate from 59.8 ± 2.4 to 79.4 ± 2.9 beats/min (P < 0.001), an increase in mean arterial pressure from 96.7 ± 2.5 to 105.0 ± 3.3 mmHg (P = 0.002), and an increase in muscle sympathetic nerve activity from 3,430 ± 800 to 6,230 ± 1,630 total integrated units/min (an increase of 126 ± 58%) compared with normoxia (P < 0.05).

Cardiovascular Regulation During Hypoxia

We gave an intravenous bolus of 100 µg sodium nitroprusside, followed 1 min later by 150 µg of phenylephrine HCl to lower and raise arterial pressure. The fall in pressure produced by nitroprusside was similar during hypoxia and normoxia (-16.2 ± 1.4 vs. -17.5 ± 1.4 mmHg; P > 0.2). Similarly, the increase in pressure above baseline produced by phenylephrine was similar during hypoxia and normoxia (15.5 ± 2.0 vs. 13.0 ± 1.2 mmHg; P > 0.1). Thus the range of pressures (maximum pressure - minimum pressure) produced by the combination of sequential nitroprusside and phenylephrine was similar during hypoxia and normoxia (31.7 ± 2.8 vs. 30.5 ± 1.7 mmHg; P > 0.4). Furthermore, hypoxia failed to alter the maximal rate of change in pressure produced by these compounds (rate of fall for hypoxia: -2.6 ± 0.3 vs. normoxia: -2.4 ± 0.2 mmHg/s, P > 0.4; rate of rise for hypoxia: 3.0 ± 0.6 vs. normoxia: 2.6 ± 0.3 mmHg/s; P > 0.4).

An example from one subject of the arterial baroreflex response relationships for heart rate and muscle sympathetic nerve activity, derived from these changes in arterial pressure, is shown in Fig. 1. Both relationships showed similar shifts upward and rightward, whereas slope was unchanged. Figure 2 shows the group average regressions between heart rate and systolic pressure and between sympathetic nerve activity and diastolic pressure. For both relationships, there was a shift in the baroreflex relationship upward and rightward as reflected by higher values for operating point pressure, heart rate, and sympathetic nerve activity in conjunction with no change in the slope of the response (Fig. 3, slope for heart rate: -1.02 ± 0.09 vs. -1.02 ± 0.11 beats · min-1 · mmHg-1; for nerve activity: -5.6 ± 0.9 vs. -6.2 ± 0.9 integrated activity · beat-1 · mmHg-1; both P > 0.05). Sample size analysis for nerve activity indicated that 58 subjects would need to be studied to demonstrate a difference in slope between normoxia and hypoxia. If we analyze our data in terms of R-R interval, we find that the slope for arterial baroreflex control of R-R interval is reduced by moderate hypoxia (slope for R-R interval: 11.2 ± 1.5 vs. 15.9 ± 1.5 ms/mmHg; P < 0.05). Table 1 shows an independent analysis of slope for heart rate and R-R interval during both the falling and rising pressure portions of the baroreflex response. No differences in baroreflex sensitivity between the falling and rising responses were observed in the data. Furthermore, there were no differences in the effect of hypoxia on baroreflex sensitivity between the falling and rising portions of the response.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   Data from a representative subject showing baroreflex relationships. A: baroreflex relationship between heart rate and systolic pressure. Under normoxic conditions (open circle ), the weighted regression was heart rate = 168 - 0.80 · pressure, r2 = 0.85. Under hypoxic conditions (), the weighted regression was heart rate = 202 - 0.80 · pressure, r2 = 0.93. B: baroreflex relationship between muscle sympathetic nerve activity (MSNA) and diastolic pressure. Under normoxic conditions (open circle ), the weighted regression was nerve activity = 425 - 5.0 · pressure, r2 = 0.95. Under hypoxic conditions (), the weighted regression was nerve activity = 678 - 6.4 · pressure, r2 = 0.85.



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Group average regressions between heart rate and systolic pressure (A) and between MSNA and diastolic pressure (B). The operating points are indicated by the circles and error bars (mean ± SE) for each condition (open circle , normoxia; , hypoxia). Solid lines, regression between pressure and effector response for normoxia (heart rate = 202 ± 14 - 1.02 ± 0.09 · pressure, r2 = 0.88 ± 0.02; nerve activity = 520 ± 82 - 5.6 ± 0.9 · pressure, r2 = 0.81 ± 0.04). Dashed lines, regression between pressure and effector response for hypoxia (heart rate = 222 ± 17 - 1.02 ± 0.11 · pressure, r2 = 0.89 ± 0.02; nerve activity = 597 ± 73 - 6.2 ± 0.9 · pressure, r2 = 0.77 ± 0.04). These data depicts a shift in the operating point to higher levels of pressure, heart rate, and MSNA without a change in sensitivity for either effector limb. Values are means ± SE (n = 16 subjects for heart rate; n = 9 subjects for MSNA).



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Individual and group average (mean ± SE) slopes for the relationship between heart rate and systolic pressure (A) and between MSNA and diastolic pressure (B) under normoxic and hypoxic conditions.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The goal of the present study was to provide insight into cardiovascular regulation during hypoxia. We tested the hypothesis that acute hypoxia would alter the sensitivity of arterial baroreflex control of both heart rate and sympathetic vasoconstrictor outflow, resulting in augmented responses for a given change in pressure. Our key finding is that baroreflex control of both heart rate and muscle sympathetic nerve activity is reset during hypoxia to higher pressures and higher levels of heart rate and sympathetic nerve activity. This resetting occurred without any discernable change in sensitivity of the arterial baroreflex.

Hypoxia and Baroreflex Control of Sympathetic Nerve Activity

To the best of our knowledge, this is the first study to assess the effects of hypoxia on baroreflex control of sympathetic nerve activity in humans. Our new findings build on prior reports of elevated muscle sympathetic nerve activity during hypoxia in humans (35, 40). However, our results contrast with the effects of hypoxia on control of sympathetic nerve activity in animal models. In several animal models, hypoxia has been shown to cause baroreflex resetting with an increase in sensitivity of sympathetic outflow to the kidney (18, 23, 31) and skeletal muscle vascular beds (31). It is unclear whether these differences are species related or are due to differences in study preparation. Some (18, 31) but not all (23) of these animal studies have relied on anesthetized, mechanically ventilated preparations.

It is interesting to note that changes in resting muscle sympathetic nerve activity do not oblige changes in sympathetic responsiveness. In fact, resetting of the arterial sympathetic baroreflex in the absence of changes in sensitivity has been observed after exercise in humans (14), and changes in sensitivity of the baroreflex can occur with (27) or without (26) concurrent changes in resting muscle sympathetic nerve activity.

Hypoxia and Baroreflex Control of Heart Rate

Several key studies have addressed the issue of whether or not hypoxia modifies baroreflex-heart rate responses in humans. The results of these studies suggest that baroreflex control of heart rate may be reduced by hypoxia (39), but results have varied (1, 6). Differences may be related to differences in data analysis methods (use of R-R interval vs. heart rate) or the degree or duration of hypoxic stress.

Changes in heart rate. A consistent confound in studies of baroreflex control of heart rate is the inverse relationship between R-R interval and heart rate. When baseline heart rate is increased, there is a disproportionate reduction in R-R interval responses because of the nonlinear relationship between R-R interval and heart rate. This issue has clouded many prior investigations on baroreflex control of heart rate and obstructed the understanding of the baroreflex resetting that occurs during exercise for many years (53). Because heart rate (and not R-R interval) is linearly related to cardiac output, heart rate relates to correction of a change in pressure by the baroreflex. Thus, when baseline heart rate is changed, it is reasonable to consider the change in heart rate (and not R-R interval) in response to changes in arterial pressure to provide insight into whether or not baroreflex function has changed. In the context of hypoxia, we found resetting of baroreflex control of heart rate occurs without alteration of the amplitude of the heart rate response to changes in pressure (i.e., no change in sensitivity). This is in agreement with prior work by Sagawa et al. (39) under conditions of moderate hypoxia (arterial saturation of 76%, similar to the present study). However, under conditions of more severe hypoxia (arterial saturation of 65%), Sagawa et al. found blunting of heart rate responses. If we interpret our data in terms of R-R interval, we find that the slope for arterial baroreflex control of R-R interval is reduced by moderate hypoxia (slope for R-R interval: 11.2 ± 1.5 vs. 15.9 ± 1.5 ms/mmHg; P < 0.05). Unlike baroreflex control of sympathetic outflow, it appears that the sensitivity of arterial baroreflex control, when assessed in terms of R-R interval, is linked to changes in resting R-R interval such that a shortening of the resting R-R interval causes a reduction in R-R interval responses. However, heart rate responses appear analogous to the muscle sympathetic nerve activity responses. It is unclear whether this is a reflection of the dual innervation of the heart or simply a mathematical artifact.

In animal studies, hypoxia has usually been shown to attenuate baroreflex control of heart rate (18, 23, 25). However, one report in conscious rabbits found that hypoxia produced a decrease in heart rate without attenuation of baroreflex control (21), and another study in anesthetized dogs found higher heart rates with hypoxia (3). Some of these inconsistencies may be related to use of anesthetic agents or species differences.

Potential Pathways

We would presume that the effects of hypoxia on baroreflex function, if due to hypoxia per se, are via stimulation of the peripheral chemoreceptors. It is not thought that central chemoreceptors respond to modest hypoxia (2). Baroreceptor and chemoreceptor projections within the medulla often coincide, and the overlap of these medullary projections provides multiple locations in which interactions between these reflexes could occur (22). Studies in animals demonstrated that activating the baroreflexes by increasing arterial pressure could attenuate peripheral chemoreflex-mediated ventilatory (17) and vascular responses to hypoxia (16, 24). Miura and Reis (28) localized these interactive effects to the paramedian reticular nuclei. We can only speculate as to whether this location is involved in the baroreflex resetting that we have observed.

On the basis of descriptions of "classic" resetting described by Eckberg and Sleight (9), Korner (20), and Rowell (34), it would appear that the peripheral chemoreflex is causing changes in autonomic outflow via pathways that are both baroreflex dependent and independent, meaning that some of the affected autonomic outflow tracts that are being activated are not under baroreflex control but that others are being activated via the baroreflex. This may be analogous to the classic baroreflex resetting observed during exercise (33).

Limitations

To simulate the physiological response to altitude, we did not interfere with the ventilatory response of our subjects. Ventilation increased with hypoxia, which led to hypocapnia. As such, the difference between trials cannot be attributed to hypoxia per se but could also be influenced by the concomitant hyperpnea and hypocapnia. The effects of changes in ventilation on muscle sympathetic nerve activity have been well documented in several studies (8, 41, 42, 45). During hyperpnea with increased tidal volumes, the inspiratory-expiratory differences in sympathetic outflow are enhanced because of feedback from the lung stretch receptors (42). Importantly, these changes in ventilation affect the within-breath modulation of muscle sympathetic nerve activity but do not alter the mean level of sympathetic activity, and these within-breath fluctuations do not alter the ability of the sympathetic nerves to be activated by other reflex mechanisms (e.g., unloading of cardiopulmonary receptors) (41, 42). A similar within-breath modulation of heart rate has been reported in animal (4, 11, 15) and human studies (7, 8) and reflects the respiratory gating of vagal outflow to the heart. Thus it is unlikely that our results are largely affected by hyperpnea. In contrast, hypocapnia is likely to reduce muscle sympathetic nerve activity and heart rate (12, 29, 43). Thus it is possible that the degree of resetting we observed would have been greater under isocapnic conditions. Therefore, although our results likely reflect the effects of hypoxia and may represent what happens during exposure to altitude, they may not reflect the responses produced by isocapnic hypoxia or hypercapnic hypoxia (e.g., during sleep apnea).

We did not randomize the order of normoxia and hypoxia trials. Therefore, there may be concern regarding the rise in blood pressure observed in the hypoxia trials. Previous studies have suggested that hypoxia causes either no change in pressure or a modest rise in pressure. For example, in Somers et al. (44), mean arterial pressure during hypoxia increased 3 mmHg above normoxic conditions. It is possible that the differences in the pressor response to hypoxia in various studies are due to the degree of hypoxia investigated, differences between hypocapnic and isocapnic hypoxia, whether or not subjects had been previously exposed to hypoxia or altitude, and differences in individual responsiveness to hypoxia.

In the context of baroreflex physiology, hysteresis has been historically defined as a change in sensitivity of the heart rate or R-R interval response to changes in pressure that is dependent on whether pressure is falling or rising (32, 37). One might argue that this is a long-standing misuse of the term hysteresis, because it is not entirely consistent with the more general definition of hysteresis. Regardless of the semantics, it is well documented but poorly understood that cardiac responses to falling and rising pressures may differ (37) and that this pattern is inconsistent across subjects (47). Thus, in the present work, we independently assessed the falling and rising pressure portions of our data, comparing normoxia and hypoxia trials. No differences in baroreflex sensitivity between the falling and rising responses were observed in the data. Furthermore, there were no differences in the effect of hypoxia on baroreflex sensitivity between the falling and rising portions of the response. However, the fact that average slopes do not differ between falling and rising responses does not obviate this issue within individuals. Thus we cannot exclude the possibility that subtle individual differences in the effect of hypoxia on baroreflex control of heart rate have been missed by this approach. In contrast to the literature regarding heart rate responses, to the best of our knowledge, no studies have documented differences in the response of muscle sympathetic nerve activity to falling vs. rising pressures.

In animal models, it is often possible to assess baroreflex responses over a wide range of pressures so that response relations encompass the reflex from threshold to saturation. Such data can often be analyzed by applying a sigmoidal model to the data. The modified Oxford method is not able to divulge the entire response relationship consistently in humans, because the nonlinear threshold and saturation regions are variably present within the pressure ranges achieved. As such, we have restricted our analysis to the linear region of the reflex response that was evident in the collected data. To do so, we have relied on visual selection by the investigator to identify the linear region on each individual baroreflex trial. Our laboratory has used this approach consistently in the past (14, 26, 27), but it may not be without limitation.

Perspectives

We are struck by the similarity between the arterial baroreflex resetting we have found to occur during acute exposure to hypoxia and that which occurs during exercise. Both hypoxia and exercise represent high-flow (high cardiac output), low-resistance states, in which local vasodilator mechanisms that attempt to secure adequate blood flow to match metabolic demand are in competition with neural vasoconstrictor reflexes attempting to maintain arterial pressure. It is possible that baroreflex resetting represents a stereotyped regulatory response that is beneficial in such states. Alternatively, arterial baroreflex resetting may be the final common pathway for numerous sympathoexcitatory reflexes such as peripheral chemoreflexes, muscle metaboreflexes, and others. In this context, baroreflex resetting causes the rise in sympathetic outflow.

Conclusions

Acute exposure to hypoxia resets baroreflex control of both heart rate and muscle sympathetic nerve activity to higher pressures and higher levels of heart rate and sympathetic nerve activity without changes in sensitivity of the arterial baroreflex.


    ACKNOWLEDGEMENTS

We thank Cara J. Weisbrod, Sarah J. Carlson, Eric G. Cornidez, and Karen P. Krucker for technical assistance. We thank Dr. Michael J. Joyner for advice. We especially thank the subjects who volunteered for this study.


    FOOTNOTES

This research was supported in part by a grant from the Wilderness Medical Society; American Heart Association, Northland Affiliate, Scientist Development Grant 30403Z; National Institutes of Health (NIH) Grant HL-65305; and NIH General Clinical Research Center Grant RR-00585 (to the Mayo Clinic, Rochester, MN).

Address for reprint requests and other correspondence: J. R. Halliwill, Exercise and Movement Science, 122 Esslinger Hall, 1240 Univ. of Oregon, Eugene, OR 97403-1240 (E-mail: halliwil{at}darkwing.uoregon.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

May 17, 2002;10.1152/japplphysiol.01103.2001

Received 2 November 2001; accepted in final form 13 May 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Bristow, JD, Brown EB, Jr, Cunningham DJC, Goode RC, Howson MG, and Sleight P. The effects of hypercapnia, hypoxia and ventilation on the baroreflex regulation of the pulse interval. J Physiol 216: 281-302, 1971.

2.   Bruce, EN, and Cherniack NS. Central chemoreceptors. J Appl Physiol 62: 389-402, 1987.

3.   Brunner, MJ, Wallace A, and MacAnespie CL. Interaction of carotid chemoreceptor and baroreceptor reflexes in anesthetized dogs. Am J Physiol Regul Integr Comp Physiol 254: R1-R10, 1988.

4.   Davidson, NS, Goldner S, and McCloskey DI. Respiratory modulation of baroreceptor and chemoreceptor reflexes affecting heart rate and cardiac vagal efferent nerve activity. J Physiol 259: 523-530, 1976.

5.   Ebert, TJ, and Cowley AW, Jr. Baroreflex modulation of sympathetic outflow during physiological increases of vasopressin in humans. Am J Physiol Heart Circ Physiol 262: H1372-H1378, 1992.

6.   Eckberg, DL, Bastow H, 3rd, and Scruby AE. Modulation of human sinus node function by systemic hypoxia. J Appl Physiol 52: 570-577, 1982.

7.   Eckberg, DL, Kifle YT, and Roberts VL. Phase relationship between normal human respiration and baroreflex responsiveness. J Physiol 304: 489-502, 1980.

8.   Eckberg, DL, Nerhed C, and Wallin GB. Respiratory modulation of muscle sympathetic and vagal cardiac outflow in man. J Physiol 365: 181-196, 1985.

9.   Eckberg, DL, and Sleight P. Human Baroreflexes in Health and Disease. New York: Oxford Univ. Press, 1992.

10.   Freitas, J, Costa O, Carvalho MJ, and DeFreitas AF. High altitude-related neurocardiogenic syncope. Am J Cardiol 77: 1021, 1996.

11.   Gandevia, SC, McCloskey DI, and Potter EK. Inhibition of baroreceptor and chemoreceptor reflexes on heart rate by afferents from the lungs. J Physiol 276: 369-381, 1978.

12.   Gregor, M, and Jänig W. Effects of systemic hypoxia and hypercapnia on cutaneous and muscle vasoconstrictor neurones to the cat's hindlimb. Pflügers Arch 368: 71-81, 1977.

13.   Halliwill, JR. Segregated signal averaging of sympathetic baroreflex responses in humans. J Appl Physiol 88: 767-773, 2000.

14.   Halliwill, JR, Taylor JA, and Eckberg DL. Impaired sympathetic vascular regulation in humans after acute dynamic exercise. J Physiol 495: 279-288, 1996.

15.   Haymet, BT, and McCloskey DI. Baroreceptor and chemoreceptor influences on heart rate during the respiratory cycle in the dog. J Physiol 245: 699-712, 1975.

16.   Heistad, DD, Abboud FM, Mark AL, and Schmid PG. Interaction of baroreceptor and chemoreceptor reflexes. Modulation of the chemoreceptor reflex by changes in baroreceptor activity. J Clin Invest 53: 1226-1236, 1974.

17.   Heistad, DD, Abboud FM, Mark AL, and Schmid PG. Effect of baroreceptor activity on ventilatory response to chemoreceptor stimulation. J Appl Physiol 39: 411-416, 1975.

18.   Iriki, M, Dorward P, and Korner PI. Baroreflex "resetting" by arterial hypoxia in the renal and cardiac sympathetic nerves of the rabbit. Pflügers Arch 370: 1-7, 1977.

19.   Jokl, E. Altitude diseases. N Engl J Med 280: 1420-1422, 1969.

20.   Korner, PI. Central nervous control of autonomic cardiovascular function. In: Handbook of Physiology. The Cardiovascular System. The Heart. Bethesda, MD: Am. Physiol. Soc, 1979, sect. 2, vol. I, chapt. 20, p. 691-739.

21.   Korner, PI, Shaw J, West MJ, Oliver JR, and Hilder RG. Integrative reflex control of heart rate in the rabbit during hypoxia and hyperventilation. Circ Res 33: 63-73, 1973.

22.   Loewy, AD. Central autonomic pathways. In: Central Regulation of Autonomic Function, edited by Loewy AD, and Spyer KM.. New York: Oxford Univ. Press, 1990, p. 88-103.

23.   Malpas, SC, Bendle RD, Head GA, and Ricketts JH. Frequency and amplitude of sympathetic discharges by baroreflexes during hypoxia in conscious rabbits. Am J Physiol Heart Circ Physiol 271: H2563-H2574, 1996.

24.   Mancia, G. Influence of carotid baroreceptors on vascular responses to carotid chemoreceptor stimulation in the dog. Circ Res 36: 270-276, 1975.

25.   Marshall, JM. Interaction between the responses to stimulation of peripheral chemoreceptors and baroreceptors: the importance of chemoreceptor activation of the defence areas. J Auton Nerv Syst 3: 389-400, 1981.

26.   Minson, CT, Halliwill JR, Young TM, and Joyner MJ. Influence of menstrual cycle on sympathetic activity, baroreflex sensitivity, and vascular transduction in young women. Circulation 101: 862-868, 2000.

27.   Minson, CT, Halliwill JR, Young TM, and Joyner MJ. Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives. Circulation 102: 1473-1476, 2000.

28.   Miura, M, and Reis DJ. The role of the solitary and paramedian reticular nuclei in mediating cardiovascular reflex responses from carotid baro- and chemoreceptors. J Physiol 223: 525-548, 1972.

29.   Morgan, BJ, Crabtree DC, Palta M, and Skatrud JB. Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol 79: 205-213, 1995.

30.   Nicholas, R, O'Meara PD, and Calonge N. Is syncope related to moderate altitude exposure? JAMA 268: 904-906, 1992.

31.   Pelletier, CL, and Shepherd JT. Effect of hypoxia on vascular responses to the carotid baroreflex. Am J Physiol 228: 331-336, 1975.

32.   Pickering, TG, Gribbon B, and Sleight P. Comparison of the reflex heart rate response to rising and falling arterial pressure in man. Cardiovasc Res 6: 277-283, 1972.

33.   Raven, PB, Potts JT, and Shi X. Baroreflex regulation of blood pressure during dynamic exercise. Exerc Sport Sci Rev 25: 365-389, 1997.

34.   Rowell, LB. Human Cardiovascular Control. New York: Oxford Univ. Press, 1993.

35.   Rowell, LB, Johnson DG, Chase PB, Comess KA, and Seals DR. Hypoxemia raises muscle sympathetic activity but not norepinephrine in resting humans. J Appl Physiol 66: 1736-1743, 1989.

36.   Rowell, LB, and Seals DR. Sympathetic activity during graded central hypovolemia in hypoxemic humans. Am J Physiol Heart Circ Physiol 259: H1197-H1206, 1990.

37.   Rudas, L, Crossman AA, Morillo CA, Halliwill JR, Tahvanainen KUO, Kuusela TA, and Eckberg DL. Human sympathetic and vagal baroreflex responses to sequential nitroprusside and phenylephrine. Am J Physiol Heart Circ Physiol 276: H1691-H1698, 1999.

38.   Sagawa, S, and Shiraki K. Changes in cardiovascular responses to orthostasis in human at a simulated altitude of 3,700m. In: High Altitude Medicine, edited by Ueda G, Reeves J, and Segiguchi M.. Matsumoto, Japan: Shinshu Univ. Press, 1992, p. 35-39.

39.   Sagawa, S, Torii R, Nagaya K, Wada F, Endo Y, and Shiraki K. Carotid baroreflex control of heart rate during acute exposure to simulated altitudes of 3,800 m and 4,300 m. Am J Physiol Regul Integr Comp Physiol 273: R1219-R1223, 1997.

40.   Saito, M, Mano T, Iwase S, Koga K, Abe H, and Yamazaki Y. Responses in muscle sympathetic activity to acute hypoxia in humans. J Appl Physiol 65: 1548-1552, 1988.

41.   Seals, DR, Suwarno NO, and Dempsey JA. Influence of lung volume on sympathetic nerve discharge in normal humans. Circ Res 67: 130-141, 1990.

42.   Seals, DR, Suwarno NO, Joyner MJ, Iber C, Copeland JG, and Dempsey JA. Respiratory modulation of muscle sympathetic nerve activity in intact and lung denervated humans. Circ Res 72: 440-454, 1993.

43.   Somers, VK, Mark AL, Zavala DC, and Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 67: 2101-2106, 1989.

44.   Somers, VK, Mark AL, Zavala DC, and Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 67: 2095-2100, 1989.

45.   St. Croix, CM, Satoh M, Morgan BJ, Skatrud JB, and Dempsey JA. Role of respiratory motor output in within-breath modulation of muscle sympathetic nerve activity in humans. Circ Res 85: 457-469, 1999.

46.   Sundlöf, G, and Wallin BG. The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol 272: 383-397, 1977.

47.   Taylor, JA, Farquhar WB, and Hunt BE. The human arterial baroreflex: isn't it hysteretical (Abstract)? Physiologist 43: 281, 2000.

48.   Weisbrod, CJ, Minson CT, Joyner MJ, and Halliwill JR. Effects of regional phentolamine on hypoxic vasodilatation in healthy humans. J Physiol 537: 613-621, 2001.

49.   Westendorp, RGJ, Blauw GJ, Frölich M, and Simons R. Hypoxic syncope. Aviat Space Environ Med 68: 410-414, 1997.


J APPL PHYSIOL 93(3):857-864
8750-7587/02 $5.00 Copyright © 2002 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. E. Hunt, R. Tamisier, G. S. Gilmartin, M. Curley, A. Anand, and J. W. Weiss
Baroreflex responsiveness during ventilatory acclimatization in humans
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1794 - H1801.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. Lador, E. Tam, M. Azabji Kenfack, M. Cautero, C. Moia, D. R. Morel, C. Capelli, and G. Ferretti
Phase I dynamics of cardiac output, systemic O2 delivery, and lung O2 uptake at exercise onset in men in acute normobaric hypoxia
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R624 - R632.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. Yamazaki, K. Takahara, R. Sone, and J. M. Johnson
Influence of hyperoxia on skin vasomotor control in normothermic and heat-stressed humans
J Appl Physiol, December 1, 2007; 103(6): 2026 - 2033.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Gujic, D. Laude, A. Houssiere, S. Beloka, J.-F. Argacha, D. Adamopoulos, O. Xhaet, J.-L. Elghozi, and P. van de Borne
Differential effects of metaboreceptor and chemoreceptor activation on sympathetic and cardiac baroreflex control following exercise in hypoxia in human
J. Physiol., November 15, 2007; 585(1): 165 - 174.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Cui, S. Durand, and C. G. Crandall
Baroreflex control of muscle sympathetic nerve activity during skin surface cooling
J Appl Physiol, October 1, 2007; 103(4): 1284 - 1289.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Masuki, J. H. Eisenach, W. G. Schrage, N. M. Dietz, C. P. Johnson, B. W. Wilkins, R. A. Dierkhising, P. Sandroni, P. A. Low, and M. J. Joyner
Arterial baroreflex control of heart rate during exercise in postural tachycardia syndrome
J Appl Physiol, October 1, 2007; 103(4): 1136 - 1142.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. H. Simmons, J. M. Manson, and J. R. Halliwill
Mild central chemoreflex activation does not alter arterial baroreflex function in healthy humans
J. Physiol., September 15, 2007; 583(3): 1155 - 1163.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. D. Monahan, D. J. Dyckman, and C. A. Ray
Effect of acute hyperlipidemia on autonomic and cardiovascular control in humans
J Appl Physiol, July 1, 2007; 103(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. W. Wilkins, W. G. Schrage, Z. Liu, K. C. Hancock, and M. J. Joyner
Systemic hypoxia and vasoconstrictor responsiveness in exercising human muscle
J Appl Physiol, November 1, 2006; 101(5): 1343 - 1350.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S.-J. C. Lusina, P. M. Kennedy, J. T. Inglis, D. C. McKenzie, N. T. Ayas, and A. W. Sheel
Long-term intermittent hypoxia increases sympathetic activity and chemosensitivity during acute hypoxia in humans
J. Physiol., September 15, 2006; 575(3): 961 - 970.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
C. J. Barrett and C. P. Bolter
The influence of heart rate on baroreceptor fibre activity in the carotid sinus and aortic depressor nerves of the rabbit
Exp Physiol, September 1, 2006; 91(5): 845 - 852.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J. P. Moore, V. E. Claydon, L. J. Norcliffe, M. C. Rivera-Ch, F. Leon-Velarde, O. Appenzeller, and R. Hainsworth
Carotid baroreflex regulation of vascular resistance in high-altitude Andean natives with and without chronic mountain sickness
Exp Physiol, September 1, 2006; 91(5): 907 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. D. Monahan, U. A. Leuenberger, and C. A. Ray
Effect of repetitive hypoxic apnoeas on baroreflex function in humans
J. Physiol., July 15, 2006; 574(2): 605 - 613.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Charkoudian, J. H. Eisenach, M. J. Joyner, S. K. Roberts, and D. E. Wick
Interactions of plasma osmolality with arterial and central venous pressures in control of sympathetic activity and heart rate in humans
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2456 - H2460.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
V. L Cooper, S. B Pearson, C. M Bowker, M. W Elliott, and R Hainsworth
Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia - a mechanism for promoting hypertension in obstructive sleep apnoea
J. Physiol., October 15, 2005; 568(2): 677 - 687.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H.-C. Yeh, N. M. Punjabi, N.-Y. Wang, J. S. Pankow, B. B. Duncan, and F. L. Brancati
Vital Capacity as a Predictor of Incident Type 2 Diabetes: The Atherosclerosis Risk in Communities study
Diabetes Care, June 1, 2005; 28(6): 1472 - 1479.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. R. Halliwill and C. T. Minson
Cardiovagal regulation during combined hypoxic and orthostatic stress: fainters vs. nonfainters
J Appl Physiol, March 1, 2005; 98(3): 1050 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Monahan and C. A. Ray
Cyclooxygenase inhibition and baroreflex sensitivity in humans
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H737 - H743.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
V. E. Claydon, L. J. Norcliffe, J. P. Moore, M. Rivera, F. Leon-Velarde, O. Appenzeller, and R. Hainsworth
Cardiovascular responses to orthostatic stress in healthy altitude dwellers, and altitude residents with chronic mountain sickness
Exp Physiol, January 1, 2005; 90(1): 103 - 110.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Ohuchi, H. Takasugi, H. Ohashi, O. Yamada, K. Watanabe, T. Yagihara, and S. Echigo
Abnormalities of Neurohormonal and Cardiac Autonomic Nervous Activities Relate Poorly to Functional Status in Fontan Patients
Circulation, October 26, 2004; 110(17): 2601 - 2608.
[Abstract] [Full Text] [PDF]